The Street’s Key Stock Analysts Research Reports
$A, $BABA, $CRSP, $DISCA, $RACE, $IRDM, $MCD, $MLNX, $MYGN, $PBPB, $TTOW
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Thursday, as follows:
Agilent Technologies Inc. (NYSE:A) was reiterated as Overweight and the price target was raised to 86 from 84 at Morgan Stanley. Agilent had a consensus analyst target of 78.79 and a 52-wk trading range of 60.42 – 75.00.
Alibaba Group Holding Ltd. (NYSE:BABA) Raymond James maintained it as Strong Buy but lowered the price target to 260 from 280. KeyBanc Capital Markets maintained it as Overweight but cut the price target to 215 from 220.
CRISPR Therapeutics A.G. (NASDAQ:CRSP) was started as Outperform with a 65 price target at Wells Fargo.
Discovery Inc. (NASDAQ:DISCA) was raised to Outperform from Neutral and the price target was raised to 40 from 30 at Credit Suisse.
Iridium Communications Inc. (NASDAQ:IRDM) was reiterated as Strong Buy and the price target was raised to 23 from 20 at Raymond James.
McDonald’s Corp. (NYSE:MCD) analysts raised MCD to Buy with a 200 price target from a prior Neutral rating at Guggenheim writing that McDonald’s has an unjustified discount to its valuation relative to peers. The stock has a consensus target price of 62.86.
Mellanox Technologies Ltd. (NASDAQ:MLNX) was started with a Buy rating and assigned a 105 target price at Merrill Lynch.
Myriad Genetics Inc. (NASDAQ:MYGN) was reiterated as Overweight and the price target was raised to 54 from 51 at Morgan Stanley, and Piper Jaffray raised its rating to Overweight from Neutral and its target to 53 from 38 in the call.
Potbelly Corp. (NASDAQ:PBPB) was upgraded to Buy from Hold and the price target was raised to 15 from 13 at Maxim Group.
Take-Two Interactive Software Inc. (NASDAQ:TTWO) was started as Outperform and assigned a 175 target price at Sanford Bernstein.
Latest posts by Paul Ebeling (see all)
- The Fed Made a Mistake Hiking Rates in December, and Has Admitted It - March 25, 2019
- Ferrari (NYSE:RACE) Built This 1-Off Supercar for Anonymous Client - March 25, 2019
- Key US Treasury Yields Lowest Since December 2017 - March 25, 2019